Aclarion (ACON) traded down -0.26 % during a 24 hours period ending at 04:38 PM Central Europe on Monday 26th. One Aclarion stock can currently be bought for about USD 1.97 on popular exchanges. Current supply of Aclarion stocks is 2.9 mn. Aclarion has a current market capitalization of USD 5.6 mn and approximately USD 19.9 k worth of Aclarion was traded on exchanges in the last 24 hours. Since last month end, Aclarion has traded -26.62 % down. Simple moving average of last 200 days is at USD 2.93. The highest price of past 52 weeks was recorded at USD 9.36 on 01/08/2026. 52 weeks low was at USD 1.85 on 10/19/2026.

Summary of the latest news for Aclarion

The article reports that ACLARION INC has announced the launch of a new product line aimed at adult users. The company highlights that the new models are engineered with a higher per‑jumper weight capacity, enhanced frame stability, and a design that delivers a controlled bounce suitable for heavier landings. ACLARION INC emphasizes the inclusion of a robust enclosure that remains firm under stronger impacts, and the product features a warranty designed to support long‑term durability. The announcement also notes that the company has received recognition for its design quality, citing awards from several reputable industry bodies. Overall, ACLARION INC’s update signals a focus on safety, performance and customer confidence in its latest adult‑oriented offerings.

Here is how related stocks have performed in the past 24 hours:

  • Ocean Power (OPTT) traded up 6.15 % and now trades at USD 0.63. Current market capitalisation for Ocean Power is USD 6.2 mn.

  • Enveric Biosciences (ENVB) traded down -4.11 % and now trades at USD 1.37. Enveric Biosciences has a market capitalisation of USD 6.3 mn.

  • Moleculin Biotech (MBRX) traded up 10.36 % and now trades at USD 6.6. Moleculin Biotech has a market capitalisation of USD 6.6 mn.

  • Fibrobiologics (FBLG) traded down -6.86 % and now trades at USD 0.9. Fibrobiologics has a market capitalisation of USD 6.6 mn.

  • Aprea Therapeutics (APRE) traded down -4.43 % and now trades at USD 0.46. Current market capitalisation for Aprea Therapeutics is USD 6.5 mn.

About Aclarion

Aclarion, Inc. is a healthcare technology company operating in the United States. They provide magnetic resonance spectroscopy (MRS) and a proprietary biomarker to optimize clinical treatments. Additionally, they use artificial intelligence to assist in quality control processes by flagging spectroscopy data that indicate a poor MRS study.